| 期刊論文1. | 蔡甫昌、林芝宇、張至寧(20080100)。研究倫理的歷史、原則與準則。臺灣醫學,12(1),107-122。 延伸查詢![new window](/gs32/images/newin.png) | 2. | (2014)。世界醫師會赫爾辛基宣言--人體醫學研究的倫理原則。臺灣醫界,57(5),46-49。 延伸查詢![new window](/gs32/images/newin.png) | 3. | 黃齡慧(2013)。臨床試驗中未預期之嚴重藥品不良反應。當代醫藥法規月刊,33。 延伸查詢![new window](/gs32/images/newin.png) | 4. | Brewer, Timothy、Colditz, Graham A.(1999)。Postmarketing surveillance and adverse drug reactions: current perspectives and future needs。Jama,281(9),824-829。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 其他1. | (20160117)。法試新藥、5住院1腦死 該國史上最嚴重有3人無法康復,http://www.appledaily.com.tw/appledaily/article/international/20160117/37015980/?utm_source=Line&utm_medium=iOS_Share&utm_campaign=%E4%BB%8A%E6%97%A5%E8%98%8B%E6%9E%9C/%E7%86%B1%E9%96%80/%E6%B3%95%E8%A9%A6%E6%96%B0%E8%97%A5%205%E4%BD%8F%E9%99%A21%E8%85%A6%E6%AD%BB。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 2. | USFDA。Adverse event means any untoward medical occurrence associated with the use of a drug in humans, whether or not considered drug related,http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDruglNDApplication/ucm362555.htm。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | |